Oncovin and Cough - a phase IV clinical study of FDA data

Summary:

Cough is reported as a side effect among people who take Oncovin (vincristine sulfate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Cyclophosphamide, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Cough when taking Oncovin. It is created by eHealthMe based on reports of 6,660 people who have side effects when taking Oncovin from the FDA, and is updated regularly.

What is Oncovin?

Oncovin has active ingredients of vincristine sulfate. eHealthMe is studying from 6,667 Oncovin users. Check the latest studies of Oncovin.

What is Cough?

Cough is found to be associated with 3,048 drugs and 3,802 conditions by eHealthMe. Check the latest studies of Cough.

On Jul, 28, 2026

6,660 people reported to have side effects when taking Oncovin.
Among them, 91 people (1.37%) have Cough.

Among these 91 people:

How long have people been on Oncovin when they have Cough? *

What is the gender of people who have Cough when taking Oncovin? *

female: 46.43 %
male: 53.57 %

What is the age of people who have Cough when taking Oncovin? *

What are other drugs people take besides Oncovin? *

What are other side effects people have besides Cough? *

Fever: 37 people, 40.66%
Dyspnea (difficult or laboured breathing): 24 people, 26.37%
Fatigue (feeling of tiredness): 21 people, 23.08%
Oedema Peripheral (superficial swelling): 20 people, 21.98%
Thrombocytopenia (decrease of platelets in blood): 19 people, 20.88%
Chest Pain: 17 people, 18.68%
Malaise (a feeling of general discomfort or uneasiness): 16 people, 17.58%
Muscle Aches (muscle pain): 16 people, 17.58%
Confusional State: 16 people, 17.58%
Feeling Abnormal: 14 people, 15.38%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 19 people, 20.88%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 12 people, 13.19%
High Blood Pressure: 12 people, 13.19%
High Blood Cholesterol: 10 people, 10.99%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 7.69%
Lymphoma (cancer that begins in immune system cells): 6 people, 6.59%
Hodgkin's Lymphoma (cancer originating from white blood cells): 4 people, 4.40%
Nausea (feeling of having an urge to vomit): 3 people, 3.30%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 2.20%
Fever: 2 people, 2.20%

* Approximation only. Some reports may have incomplete information.

Do you take Oncovin and have Cough?

- Check whether Cough is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oncovin:

Oncovin (6,667 reports)

Cough treatments and more:

Cough (361,791 reports)

Browse all side effects of Oncovin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cough:

Cough (3,048 drugs)

Browse all the conditions that are associated with Cough:

Cough (3,802 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vincristine sulfate (the active ingredients of Oncovin) and Oncovin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.